These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35063026)

  • 1. Immunogenic characteristics of the outer membrane phosphoporin as a vaccine candidate against Klebsiella pneumoniae.
    Hu G; Chen X; Chu W; Ma Z; Miao Y; Luo X; Fu Y
    Vet Res; 2022 Jan; 53(1):5. PubMed ID: 35063026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective efficacy of DNA vaccines encoding outer membrane protein A and OmpK36 of Klebsiella pneumoniae in mice.
    Kurupati P; Ramachandran NP; Poh CL
    Clin Vaccine Immunol; 2011 Jan; 18(1):82-8. PubMed ID: 21048001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with the outer membrane proteins OmpK17 and OmpK36 elicits protection against Klebsiella pneumoniae in the murine infection model.
    Hussein KE; Bahey-El-Din M; Sheweita SA
    Microb Pathog; 2018 Jun; 119():12-18. PubMed ID: 29626658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with a trivalent Klebsiella pneumoniae vaccine confers protection in a murine model of pneumonia.
    Chen Z; Gou Q; Yuan Y; Zhang X; Zhao Z; Liao J; Zeng X; Jing H; Jiang S; Zhang W; Zeng H; Huang W; Zou Q; Zhang J
    Vaccine; 2024 Oct; 42(23):126217. PubMed ID: 39163713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Evaluation of Recombinant Outer Membrane Proteins as Vaccine Candidates Against
    Zhang BZ; Hu D; Dou Y; Xiong L; Wang X; Hu J; Xing SZ; Li W; Cai JP; Jin M; Zhang M; Lin Q; Li M; Yuen KY; Huang JD
    Front Immunol; 2021; 12():730116. PubMed ID: 34745099
    [No Abstract]   [Full Text] [Related]  

  • 6. Membrane Vesicles Derived from Bordetella bronchiseptica: Active Constituent of a New Vaccine against Infections Caused by This Pathogen.
    Bottero D; Zurita ME; Gaillard ME; Bartel E; Vercellini C; Hozbor D
    Appl Environ Microbiol; 2018 Feb; 84(4):. PubMed ID: 29180369
    [No Abstract]   [Full Text] [Related]  

  • 7. Co-immunization with DNA vaccines encoding yidR and IL-17 augments host immune response against
    Lv Z; Zhang X; Zhao K; Du L; Wang X; Chu Y; Huang T
    Virulence; 2024 Dec; 15(1):2345019. PubMed ID: 38656137
    [No Abstract]   [Full Text] [Related]  

  • 8. Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever.
    Das S; Chowdhury R; Pal A; Okamoto K; Das S
    Immunobiology; 2019 May; 224(3):371-382. PubMed ID: 30952553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model.
    Paul S; Peddayelachagiri BV; Nagaraj S; Kingston JJ; Batra HV
    Mol Immunol; 2018 Jul; 99():9-18. PubMed ID: 29649688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico and in vivo Investigations of the Immunoreactivity of Klebsiella pneumoniae OmpA Protein as a Vaccine Candidate.
    Shahbazi S; Badmasti F; Habibi M; Sabzi S; Noori Goodarzi N; Farokhi M; Asadi Karam MR
    Iran Biomed J; 2024 Jul; 28(4):156-67. PubMed ID: 38946021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge.
    Pal S; Theodor I; Peterson EM; de la Maza LM
    Infect Immun; 1997 Aug; 65(8):3361-9. PubMed ID: 9234798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine.
    Fairley SJ; Singh SR; Yilma AN; Waffo AB; Subbarayan P; Dixit S; Taha MA; Cambridge CD; Dennis VA
    Int J Nanomedicine; 2013; 8():2085-99. PubMed ID: 23785233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa.
    Hegerle N; Choi M; Sinclair J; Amin MN; Ollivault-Shiflett M; Curtis B; Laufer RS; Shridhar S; Brammer J; Toapanta FR; Holder IA; Pasetti MF; Lees A; Tennant SM; Cross AS; Simon R
    PLoS One; 2018; 13(9):e0203143. PubMed ID: 30188914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elicitation of Th1/Th2 related responses in mice by chitosan nanoparticles loaded with Brucella abortus malate dehydrogenase, outer membrane proteins 10 and 19.
    Shim S; Soh SH; Im YB; Park HE; Cho CS; Kim S; Yoo HS
    Int J Med Microbiol; 2020 Jan; 310(1):151362. PubMed ID: 31676233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxin.
    Cheng C; Bettahi I; Cruz-Fisher MI; Pal S; Jain P; Jia Z; Holmgren J; Harandi AM; de la Maza LM
    Vaccine; 2009 Oct; 27(44):6239-46. PubMed ID: 19686693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors.
    Cheng C; Jain P; Bettahi I; Pal S; Tifrea D; de la Maza LM
    Vaccine; 2011 Sep; 29(38):6641-9. PubMed ID: 21742006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of immune response and protective efficacy of recombinant outer-membrane protein F (rOmpF) of Aeromonas hydrophila in Labeo rohita.
    Yadav SK; Dash P; Sahoo PK; Garg LC; Dixit A
    Fish Shellfish Immunol; 2018 Sep; 80():563-572. PubMed ID: 29958980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen.
    Hadad R; Marks E; Kalbina I; Schön K; Unemo M; Lycke N; Strid Å; Andersson S
    APMIS; 2016 Dec; 124(12):1078-1086. PubMed ID: 27859689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combined subunit vaccine comprising BP26, Omp25 and L7/L12 against brucellosis.
    Gupta S; Singh D; Gupta M; Bhatnagar R
    Pathog Dis; 2019 Nov; 77(8):. PubMed ID: 31971564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge.
    Pal S; Theodor I; Peterson EM; de la Maza LM
    Infect Immun; 2001 Oct; 69(10):6240-7. PubMed ID: 11553566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.